Cargando…
IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination
Allergic reactions after vaccination are considered as an important practical problem in dogs; however, their immunological mechanism has not been well understood. The present study was designed to investigate the relationship between IgE reactivity to the vaccines and immediate-type allergic reacti...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112531/ https://www.ncbi.nlm.nih.gov/pubmed/15734545 http://dx.doi.org/10.1016/j.vetimm.2004.12.003 |
_version_ | 1783513492804861952 |
---|---|
author | Ohmori, Keitaro Masuda, Kenichi Maeda, Sadatoshi Kaburagi, Yukiko Kurata, Keigo Ohno, Koichi DeBoer, Douglas J. Tsujimoto, Hajime Sakaguchi, Masahiro |
author_facet | Ohmori, Keitaro Masuda, Kenichi Maeda, Sadatoshi Kaburagi, Yukiko Kurata, Keigo Ohno, Koichi DeBoer, Douglas J. Tsujimoto, Hajime Sakaguchi, Masahiro |
author_sort | Ohmori, Keitaro |
collection | PubMed |
description | Allergic reactions after vaccination are considered as an important practical problem in dogs; however, their immunological mechanism has not been well understood. The present study was designed to investigate the relationship between IgE reactivity to the vaccines and immediate-type allergic reactions after vaccination in dogs. Sera from 10 dogs that developed immediate-type allergic reactions such as circulatory collapse, cyanosis, dyspnea, facial edema, and vomiting within 1 h after vaccination with non-rabies monovalent or combined vaccines and sera from 50 dogs that did not develop allergic reactions after vaccination were collected. Serum IgE reactivity to the injected vaccines was measured by fluorometric ELISA using a mouse monoclonal anti-dog IgE antibody. Then, IgE reactivity to fetal calf serum (FCS) and stabilizer proteins (gelatin, casein, and peptone) included in the vaccines was measured in sera that had high levels of IgE to the vaccines. Levels of serum specific IgE to the vaccines in dogs with immediate-type allergic reactions (59–4173 fluorescence units [FU], mean ± S.D.: 992.5 ± 1181.9 FU) were significantly higher than those in control dogs (38–192 FU, 92.4 ± 43.3 FU) (P < 0.001). Of the eight dogs that developed immediate-type allergic reactions and had high levels of serum specific IgE to the vaccines, seven had specific IgE directed to FCS. The IgE reactivity to the vaccines in sera from these dogs was almost completely inhibited by FCS. The other one dog had serum IgE directed to gelatin and casein included in the vaccine as stabilizers. The results obtained in this study suggest that immediate-type allergic reactions after vaccination in dogs were induced by type I hypersensitivity mediated by IgE directed to vaccine components. In addition, FCS, gelatin, and casein included in vaccines could be the causative allergens that induced immediate-type allergic reactions after vaccination in dogs. |
format | Online Article Text |
id | pubmed-7112531 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2005 |
publisher | Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-71125312020-04-02 IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination Ohmori, Keitaro Masuda, Kenichi Maeda, Sadatoshi Kaburagi, Yukiko Kurata, Keigo Ohno, Koichi DeBoer, Douglas J. Tsujimoto, Hajime Sakaguchi, Masahiro Vet Immunol Immunopathol Article Allergic reactions after vaccination are considered as an important practical problem in dogs; however, their immunological mechanism has not been well understood. The present study was designed to investigate the relationship between IgE reactivity to the vaccines and immediate-type allergic reactions after vaccination in dogs. Sera from 10 dogs that developed immediate-type allergic reactions such as circulatory collapse, cyanosis, dyspnea, facial edema, and vomiting within 1 h after vaccination with non-rabies monovalent or combined vaccines and sera from 50 dogs that did not develop allergic reactions after vaccination were collected. Serum IgE reactivity to the injected vaccines was measured by fluorometric ELISA using a mouse monoclonal anti-dog IgE antibody. Then, IgE reactivity to fetal calf serum (FCS) and stabilizer proteins (gelatin, casein, and peptone) included in the vaccines was measured in sera that had high levels of IgE to the vaccines. Levels of serum specific IgE to the vaccines in dogs with immediate-type allergic reactions (59–4173 fluorescence units [FU], mean ± S.D.: 992.5 ± 1181.9 FU) were significantly higher than those in control dogs (38–192 FU, 92.4 ± 43.3 FU) (P < 0.001). Of the eight dogs that developed immediate-type allergic reactions and had high levels of serum specific IgE to the vaccines, seven had specific IgE directed to FCS. The IgE reactivity to the vaccines in sera from these dogs was almost completely inhibited by FCS. The other one dog had serum IgE directed to gelatin and casein included in the vaccine as stabilizers. The results obtained in this study suggest that immediate-type allergic reactions after vaccination in dogs were induced by type I hypersensitivity mediated by IgE directed to vaccine components. In addition, FCS, gelatin, and casein included in vaccines could be the causative allergens that induced immediate-type allergic reactions after vaccination in dogs. Elsevier B.V. 2005-04-08 2005-01-11 /pmc/articles/PMC7112531/ /pubmed/15734545 http://dx.doi.org/10.1016/j.vetimm.2004.12.003 Text en Copyright © 2004 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Ohmori, Keitaro Masuda, Kenichi Maeda, Sadatoshi Kaburagi, Yukiko Kurata, Keigo Ohno, Koichi DeBoer, Douglas J. Tsujimoto, Hajime Sakaguchi, Masahiro IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination |
title | IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination |
title_full | IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination |
title_fullStr | IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination |
title_full_unstemmed | IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination |
title_short | IgE reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination |
title_sort | ige reactivity to vaccine components in dogs that developed immediate-type allergic reactions after vaccination |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112531/ https://www.ncbi.nlm.nih.gov/pubmed/15734545 http://dx.doi.org/10.1016/j.vetimm.2004.12.003 |
work_keys_str_mv | AT ohmorikeitaro igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination AT masudakenichi igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination AT maedasadatoshi igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination AT kaburagiyukiko igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination AT kuratakeigo igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination AT ohnokoichi igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination AT deboerdouglasj igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination AT tsujimotohajime igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination AT sakaguchimasahiro igereactivitytovaccinecomponentsindogsthatdevelopedimmediatetypeallergicreactionsaftervaccination |